U.S. Markets closed

Innovus Pharmaceuticals, Inc. (INNV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1075+0.01 (+9.69%)
At close: 3:58PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,818.603735.7171,030.113
Cost of Revenue1,083.094340.713292.08
Gross Profit3,735.509395.004738.033
Operating Expenses
Research Development77.80477.804143.914
Selling General and Administrative9,491.6173,910.1924,378.749
Non Recurring-759.428759.428
Total Operating Expenses---
Operating Income or Loss-5,833.912-4,274.616-3,784.63
Income from Continuing Operations
Total Other Income/Expenses Net-1,203.148468.336-510.107
Earnings Before Interest and Taxes-7,037.06-3,806.28-4,294.737
Interest Expense6,661.6941,153.376532.23
Income Before Tax-13,698.754-4,959.656-4,826.967
Income Tax Expense2.4-757.028-
Minority Interest---
Net Income From Continuing Ops-13,701.154-4,235.128-5,233.8
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,701.154-4,202.628-4,826.967
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,701.154-4,202.628-4,826.967